Related Experiment Video
Updated: Jul 20, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial DNA sequence variation in single cells from leukemia patients
Yong-Gang Yao1, Yoji Ogasawara, Sachiko Kajigaya
1Hematology Branch and Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, NIH Bldg 10 CRC, Rm 3E-5216, 10 Center Dr Bethesda, MD 20892, USA. yaoy3@nhlbi.nih.gov
Blood
|September 2, 2006
Summary
Mitochondrial DNA (mtDNA) somatic mutations differ significantly in leukemia patients compared to healthy individuals. Specific mtDNA mutations may serve as markers for leukemia progression, highlighting the complexity of these genetic alterations.
Area of Science:
- Genetics
- Cell Biology
- Oncology
Background:
- Somatic mutations in mitochondrial DNA (mtDNA) are frequently observed in tumors and aging tissues.
- Understanding mtDNA variation in leukemia is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To analyze mtDNA control region sequence variation in single cells from leukemia patients and healthy donors.
- To investigate the mutation process in leukemic cells and identify potential disease markers.
Main Methods:
- Analysis of mtDNA control region sequence variation in 3534 single normal cells and individual blasts.
- Comparison of mtDNA sequence variation between 18 leukemia patients and 10 healthy donors.
- Identification of specific mutations and their clonal expansion patterns.
Main Results:
- Significant differences in mtDNA sequence variation (haplotypes, cell populations) were found between leukemia patients and controls.
- Leukemia patients, including those with acute myeloid leukemia (AML), showed non-uniform mtDNA sequence variation patterns.
- Four patients exhibited high frequencies of specific mtDNA mutations (189, 260, 16150, 16488) due to clonal expansion, suggesting potential disease markers.
Conclusions:
- The somatic mutation process in leukemia is complex, with diverse genetic alterations.
- mtDNA variation in leukemia may be influenced by intrinsic pathophysiology or chemotherapy effects.
- Specific mtDNA mutations identified in this large-scale single-cell study could serve as markers for disease progression.
